aid: alphina-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alphina-therapeutics.png
name: Alphina Therapeutics
description: Alphina Therapeutics is a New Haven, Connecticut precision-oncology biotechnology company
  founded by experts in DNA repair and metabolic lethality. It develops next-generation antibody-drug
  conjugates (ADCs) that deliver potent NAMPT inhibitor payloads directly to tumors, designed to kill
  both dividing and non-dividing cancer cells, and pairs them with a proprietary companion diagnostic
  that identifies the patients most likely to respond. The company is venture-backed by Canaan Partners.
  It was surfaced as a portfolio company and added to the API Evangelist network as a stub; it publishes
  no public developer program, API, SDK, or documentation, so no API artifacts apply at this time.
url: https://raw.githubusercontent.com/api-evangelist/alphina-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Oncology
- Therapeutics
- Antibody-Drug Conjugates
- Precision Medicine
- Life Sciences
apis: []
common:
- type: Website
  url: https://www.alphinatx.com/
- type: Blog
  name: News
  url: https://www.alphinatx.com/news/
- type: LinkedIn
  url: https://www.linkedin.com/company/alphina-therapeutics
- type: Twitter
  url: https://twitter.com/alphinatx
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence